about
Influence of Adalimumab on the Expression Profile of Genes Associated with the Histaminergic System in the Skin Fibroblasts In Vitro.Psoriasis Treatment Changes the Expression Profile of Selected Caspases and their Regulatory MicroRNAsClinical and molecular evaluation of therapy with the use of cyclosporine A in patients with psoriasis vulgarisGenes involved in the regulation of different types of autophagy and their participation in cancer pathogenesisEffect of adalimumab on the expression of genes encoding TNF-α signal paths in skin fibroblastsExpression Profile of Genes Associated with the Proteins Degradation Pathways in Colorectal adenocarcinoma.The impact of diabetes and metabolic syndromes to the effectiveness of cyclosporine a pharmacotherapy in psoriatic patients.The analysis of the therapeutic potential of ustekinumab in psoriasis vulgaris treatment.Are new variants of psoriasis therapy (IL-17 inhibitors) safe?Effect of ursodeoxycholic acid therapy due to pregnant intrahepatic cholestasis on chemerin and irisin levelsAdalimumab changes the expression profile of selected BCL-2 family genesAnalysis of the clinical response and changes in the expression of TNF-α and its TNFR1 and TNFR2 receptors in patients with psoriasis vulgaris treated with ustekinumabIs ursodeoxycholic acid therapy due to pregnant intrahepatic cholestasis change the adiponectin and fibroblast growth factor-21 levels?-Pilot studyAssessment of the Usefulness of the SEMA5A Concentration Profile Changes as a Molecular Marker in Endometrial CancerChanges in the Expression Profile of JAK/STAT Signaling Pathway Genes and Mirnas Regulating their Expression Under the Adalimumab TherapyAssessment of transcriptional activity genes associated with the IL-17 signaling pathway in skin fibroblasts under the influence of adalimumabBMI changes and concentration of selected morphological and biochemical indices during cyclosporin A therapyEvaluation of expression pattern of selected genes associated with IL12/23 signaling paths in psoriatic patients during cyclosporine A therapyEvaluation of changes in expression pattern of oxidative stress genes under the influence of adalimumabEvaluation of Changes in the Expression Pattern of EDIL3 in Different Grades of Endometrial Cancer.Changes in Expression Pattern of SEMA3F Depending on Endometrial Cancer Grade - Pilot Study.Expression of Semaphorin 3B (SEMA3B) in Various Grades of Endometrial Cancer.Changes in the Expression Profile of VEGF-A, VEGF-B, VEGFR-1, VEGFR-2 in Different Grades of Endometrial Cancer.Expression Profile of VEGF-C, VEGF-D, and VEGFR-3 in Different Grades of Endometrial Cancer.The Capability to Forecast Response to Therapy with Regard to The Time and Intensity of The Inflammatory Process in vitro in Dermal Fibroblasts Induced by IL-12Values of body mass index (BMI) and body surface area (BSA) in patients with psoriatic arthritis treated with adalimumab: Preliminary reportThe influence of adalimumab on the expression profile of mRNAs and miRNAs related to the IL-12 and IL-23 signal pathsInterplay between miRNAs and Genes Associated with Cell Proliferation in Endometrial CancerEffect of adalimumab on the expression profile of mRNA, and protein associated with JAK/STAT signaling pathway in fibroblast exposed to lipopolysaccharideExpression of NRP-1 and NRP-2 in Endometrial CancerThe influence of ustekinumab on expression of STAT1, STAT3, STAT4, SOCS2, and IL17 in patients with psoriasis and in a controlChanges in the Density of Corneal Endothelial Cells in Elderly Diabetic Patients After Combined Phacovitrectomy and Ex-PRESS Glaucoma ImplantsVariances in the mRNA expression profile of TGF-β1-3 isoforms and its TGF-βRI-III receptors during cyclosporin a treatment of psoriatic patientsExpression Profile of Endoglin in Different Grades of Endometrial CancerEvaluation of changes in expression profile of mRNA and protein encoding adiponectin in Ishikawa cell line under influence of cisplatin - preliminary reportEffect of salinomycin on expression pattern of genes associated with apoptosis in endometrial cancer cell lineThe Influence of Salinomycin on the Expression Profile of mRNAs Encoding Selected Caspases and MiRNAs Regulating their Expression in Endometrial Cancer Cell LineCisplatin changes expression of SEMA3B in endometrial cancerEvaluation of the Impact of Cisplatin on Variances in the Expression Pattern of Leptin-Related Genes in Endometrial Cancer CellsSalinomycin Modulates the Expression of mRNAs and miRNAs Related to Stemness in Endometrial Cancer
P50
Q50296996-67C44D83-4005-4002-A70D-60B94CD7A3F3Q57280000-4A1F753D-DD34-4922-9CAB-8ADAF8410B8FQ57803154-D038E88E-D1D4-4437-9366-56F345EDC2DDQ57821047-0BBE8E66-691B-47AF-9ADE-C27DCED4BF27Q58727126-898D0102-79A1-4AB7-AC3E-DCBEBEC74837Q68097913-ACBC2E1E-DD1F-455B-8CEF-F25FD7C3A332Q68097917-9353CF60-C0F3-46DC-AAB6-D293E187D847Q68097920-A308AC37-71A5-4841-8081-0C532239ADC1Q68097922-A849F8B9-5847-400D-B34E-2936A4316564Q89726034-DD0075FF-83CD-4055-B2C1-7F8AFA137CA5Q89757652-4807323F-3A4D-486C-AC1F-24E4CAC434F2Q89990391-4500F99A-300E-4DBF-BFC7-CC56B1752E92Q90154590-916274C7-E3A0-4940-9541-B14E24E92F16Q90211179-9F335987-1242-4C55-9A9B-7EC6AA5C5AA1Q90605539-E8A87CD4-C248-481E-A001-7E8A9AB69CA3Q90667007-A4765E7D-9AD4-40A5-AAEF-2550EEF7DD67Q90815292-38C50743-EFB9-42F2-B85E-3EFD0CBA9E97Q90831703-15074034-5C02-42C0-8EA9-E011D3BAED39Q91003424-6E946E42-0C8E-4839-B54A-F604A77FFBACQ91013263-DBBB4262-551D-431D-B06D-29D1B9B1FAFEQ91013501-1B31B296-E6C1-41B7-B1DB-AB15BF9FC998Q91013522-D347381D-EC55-4D5F-A90F-202AB1544CE3Q91013698-8EBF4734-B523-4D90-A34C-F4893AA3C8CFQ91013704-F2037145-737D-4F9C-ACAE-DCF7D4F1111CQ91017488-63878136-D23D-4C2C-9AB2-6B1823FC7D3DQ91269203-5315B6F6-01DB-4EDE-9BC0-E7E5A9FC683BQ91304229-77E24E46-089B-48D6-94ED-CA3B997E25B2Q91645027-6AC458A1-1F5F-4721-9123-2E1B94E690C1Q91809930-E1E13AA3-BA74-4131-9938-59FCD65AF578Q91922061-989AD5AC-9093-4407-8312-70B23865387EQ92076321-36AC1153-E6C5-4049-8220-5B12126DFB9AQ92494514-488E55A3-AAB0-44D1-949B-25B4A1A449B3Q93081913-CD2ABC85-2C4A-4623-A3DC-847D06AFDDDCQ93385745-52485475-7C1A-4397-A8DA-19B7C8586121Q94547037-9703DF3A-8CC3-49B7-B30C-A8EC5B9654BCQ94648807-D9CB551A-33C8-4299-9262-7734417976BCQ94678965-4A5C51B4-6118-48A6-9752-EDEB213F78BEQ94917330-65805262-EBA2-4CE9-BA7D-3FC01CCDF3F4Q96345261-428F95EC-454B-4389-B625-8724540572F2Q96619006-D2CE0DD6-D7A8-4787-830E-945686D1C4BA
P50
description
researcher ORCID ID = 0000-0003-1633-7145
@en
wetenschapper
@nl
name
Beniamin Grabarek
@ast
Beniamin Grabarek
@ca
Beniamin Grabarek
@cs
Beniamin Grabarek
@en
Beniamin Grabarek
@es
Beniamin Grabarek
@gl
Beniamin Grabarek
@hr
Beniamin Grabarek
@hsb
Beniamin Grabarek
@it
Beniamin Grabarek
@nl
type
label
Beniamin Grabarek
@ast
Beniamin Grabarek
@ca
Beniamin Grabarek
@cs
Beniamin Grabarek
@en
Beniamin Grabarek
@es
Beniamin Grabarek
@gl
Beniamin Grabarek
@hr
Beniamin Grabarek
@hsb
Beniamin Grabarek
@it
Beniamin Grabarek
@nl
prefLabel
Beniamin Grabarek
@ast
Beniamin Grabarek
@ca
Beniamin Grabarek
@cs
Beniamin Grabarek
@en
Beniamin Grabarek
@es
Beniamin Grabarek
@gl
Beniamin Grabarek
@hr
Beniamin Grabarek
@hsb
Beniamin Grabarek
@it
Beniamin Grabarek
@nl
P1412
P1559
Beniamin Grabarek
@pl
P21
P214
56153530872548700226
P27
P31
P496
0000-0003-1633-7145
P735
P7859
viaf-56153530872548700226